PT3628002T - Composições de formação de espuma para entregar um activo a uma cavidade corporal - Google Patents
Composições de formação de espuma para entregar um activo a uma cavidade corporalInfo
- Publication number
- PT3628002T PT3628002T PT187290598T PT18729059T PT3628002T PT 3628002 T PT3628002 T PT 3628002T PT 187290598 T PT187290598 T PT 187290598T PT 18729059 T PT18729059 T PT 18729059T PT 3628002 T PT3628002 T PT 3628002T
- Authority
- PT
- Portugal
- Prior art keywords
- delivering
- foam
- active
- body cavity
- forming compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762509932P | 2017-05-23 | 2017-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3628002T true PT3628002T (pt) | 2023-05-10 |
Family
ID=62528409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187290598T PT3628002T (pt) | 2017-05-23 | 2018-05-22 | Composições de formação de espuma para entregar um activo a uma cavidade corporal |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11135166B2 (pt) |
| EP (1) | EP3628002B1 (pt) |
| JP (1) | JP7364556B2 (pt) |
| KR (1) | KR20200009079A (pt) |
| CN (1) | CN110785163B (pt) |
| AU (1) | AU2018272880B2 (pt) |
| BR (1) | BR112019024334A2 (pt) |
| CA (1) | CA3063208A1 (pt) |
| DK (1) | DK3628002T3 (pt) |
| ES (1) | ES2947949T3 (pt) |
| FI (1) | FI3628002T3 (pt) |
| HU (1) | HUE062093T2 (pt) |
| PL (1) | PL3628002T3 (pt) |
| PT (1) | PT3628002T (pt) |
| WO (1) | WO2018215474A1 (pt) |
| ZA (1) | ZA201907825B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240036492A (ko) | 2021-01-27 | 2024-03-20 | 펩토닉 메디컬 에이비 | 생물막 분해 또는 생물막 형성 방지에 사용하기 위한 조성물 |
| CA3175700A1 (en) * | 2021-06-11 | 2022-12-11 | Ankh Life Sciences Limited | Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684479A (en) | 1985-08-14 | 1987-08-04 | Arrigo Joseph S D | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures |
| SE454397B (sv) | 1985-12-20 | 1988-05-02 | Biogram Ab | Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur |
| JPH06279228A (ja) | 1993-03-30 | 1994-10-04 | Kao Corp | 発泡性組成物 |
| US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| JPH07197083A (ja) | 1993-12-28 | 1995-08-01 | Kao Corp | 洗浄剤組成物 |
| GB9822419D0 (en) | 1998-10-14 | 1998-12-09 | Unilever Plc | Hair styling composition |
| GB9909711D0 (en) | 1999-04-27 | 1999-06-23 | Unilever Plc | Mousse forming hair treatment composition |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US7709026B2 (en) | 2001-10-29 | 2010-05-04 | Columbia Laboratories, Inc. | Low concentration of peroxide for treating or preventing vaginal infections |
| AU2003244636A1 (en) | 2002-07-22 | 2004-02-09 | Unilever Plc | Hair care composition |
| US20070292355A1 (en) | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
| EP1592420B1 (en) | 2003-01-24 | 2014-01-01 | Stiefel Research Australia Pty Ltd | Clindamycin phosphate foam |
| US8193244B1 (en) | 2008-05-29 | 2012-06-05 | Nevada Naturals, Inc. | Antimicrobial agents |
| EP2977043A3 (en) * | 2003-08-25 | 2016-04-06 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
| US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| CA2565754A1 (en) | 2004-04-28 | 2005-10-28 | Foamix Ltd. | Body cavity foams |
| WO2006099325A2 (en) | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of treating ear infections |
| US20070299043A1 (en) | 2005-10-03 | 2007-12-27 | Hunter William L | Anti-scarring drug combinations and use thereof |
| WO2007079069A1 (en) | 2005-12-29 | 2007-07-12 | 3M Innovative Properties Company | Foamable dental compositions and methods |
| WO2008075207A2 (en) | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
| WO2011039638A2 (en) | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Topical tetracycline compositions |
| US8414868B2 (en) * | 2010-02-04 | 2013-04-09 | Ultradent Products, Inc. | In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions |
| BR112015027026A8 (pt) * | 2013-04-26 | 2018-01-30 | Bioglan Ab | composição para uso na redução da formação de casca e na promoção da cicatrização |
| EP3036353B1 (en) | 2013-08-20 | 2022-01-26 | MDS Coating Technologies Corp. | Coating containing macroparticles and cathodic arc process of making the coating |
| US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
-
2018
- 2018-05-22 KR KR1020197037665A patent/KR20200009079A/ko not_active Application Discontinuation
- 2018-05-22 PL PL18729059.8T patent/PL3628002T3/pl unknown
- 2018-05-22 EP EP18729059.8A patent/EP3628002B1/en active Active
- 2018-05-22 PT PT187290598T patent/PT3628002T/pt unknown
- 2018-05-22 FI FIEP18729059.8T patent/FI3628002T3/fi active
- 2018-05-22 HU HUE18729059A patent/HUE062093T2/hu unknown
- 2018-05-22 BR BR112019024334-8A patent/BR112019024334A2/pt unknown
- 2018-05-22 US US15/985,751 patent/US11135166B2/en active Active
- 2018-05-22 DK DK18729059.8T patent/DK3628002T3/da active
- 2018-05-22 WO PCT/EP2018/063397 patent/WO2018215474A1/en active Application Filing
- 2018-05-22 CN CN201880042046.6A patent/CN110785163B/zh active Active
- 2018-05-22 JP JP2020515284A patent/JP7364556B2/ja active Active
- 2018-05-22 CA CA3063208A patent/CA3063208A1/en active Pending
- 2018-05-22 AU AU2018272880A patent/AU2018272880B2/en active Active
- 2018-05-22 ES ES18729059T patent/ES2947949T3/es active Active
-
2019
- 2019-11-26 ZA ZA2019/07825A patent/ZA201907825B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3628002B1 (en) | 2023-03-22 |
| ES2947949T3 (es) | 2023-08-24 |
| HUE062093T2 (hu) | 2023-09-28 |
| EP3628002A1 (en) | 2020-04-01 |
| RU2019137562A (ru) | 2021-06-23 |
| KR20200009079A (ko) | 2020-01-29 |
| AU2018272880B2 (en) | 2024-02-29 |
| CN110785163A (zh) | 2020-02-11 |
| US20180338916A1 (en) | 2018-11-29 |
| WO2018215474A1 (en) | 2018-11-29 |
| ZA201907825B (en) | 2021-04-28 |
| BR112019024334A2 (pt) | 2020-06-16 |
| DK3628002T3 (da) | 2023-06-06 |
| JP7364556B2 (ja) | 2023-10-18 |
| PL3628002T3 (pl) | 2023-07-31 |
| AU2018272880A1 (en) | 2019-12-12 |
| JP2020521001A (ja) | 2020-07-16 |
| US11135166B2 (en) | 2021-10-05 |
| CN110785163B (zh) | 2023-09-05 |
| RU2019137562A3 (pt) | 2021-08-27 |
| CA3063208A1 (en) | 2018-11-29 |
| FI3628002T3 (fi) | 2023-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201806163B (en) | Microneedle patch for delivering an active ingredient to skin | |
| HK1252512A1 (zh) | 向眼部遞送藥劑的方法 | |
| SI3455179T1 (sl) | Stisnjeno telo | |
| EP3532110C0 (en) | FORMULATION FOR THE SUPPLY OF OXYGEN TO BODY TISSUES | |
| SG11202005535UA (en) | Combination drug including tlr7 agonist | |
| IL242545B (en) | Compositions and methods for administering hydrophobic active substances | |
| ZA201806822B (en) | Injectable composition for delivery of a biologically active agent | |
| HUE062224T2 (hu) | Habképzõ kompozíciók és eljárások hatóanyag eljuttatására egy testüregbe | |
| GB201621418D0 (en) | Cosmetic agent comprising a combination of two mutually different active agents | |
| GB201714115D0 (en) | Cytotoxic agents | |
| EP3139874A4 (en) | Condom having a foam tip | |
| HK1247556A1 (zh) | 難溶性藥物傳遞用的可溶性微針 | |
| ZA201907825B (en) | Foam-forming compositions for delivering an active to a body cavity | |
| EP3313380A4 (en) | COMPOSITION FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO AN ANIMAL | |
| IL272271A (en) | A therapeutic agent for fibrosis | |
| GB201518078D0 (en) | Model generation for drug determination | |
| HK1249059A1 (zh) | 用於額葉功能障礙的治療性藥劑 | |
| GB201316023D0 (en) | Continuous low dosing of an active ingredient | |
| IL249121A0 (en) | Intravaginal formulations containing gnrh | |
| IL272896A (en) | Push-fit earplugs with an end cavity | |
| PT3273942T (pt) | Penso de microagulhas para administração de um ingrediente ativo na pele | |
| EP3430011A4 (en) | NOVEL ACTIVE SUBSTANCE | |
| EP3147100A4 (en) | Foam molded body |